Managing SQL Server across hybrid and multi-cloud environments has long posed a challenge for database administrators. With data sprawled across on-premises infrastructure, cloud platforms, and edge ...

Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset reduced a painful complication of sickle cell disease (SCD) in a phase 3 study.

The water restrictions taking effect Monday in Raleigh are expected to last more than a month, according to a city spokesperson. City of Raleigh environmental coordinator Ed Buchan estimated that the ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...

Denver Board of Water Commissioners adopted a resolution approving the implementation of temporary drought pricing at a meeting Wednesday. Denver Water said that the drought pricing will apply ...

Employer cost coverage increases likelihood of GLP-1 use (65% overall), peaking in ages 35–44 (75%) and declining sharply among workers ≥65 (37%). Behavioral support programs shift willingness to self ...

The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

A box blade can handle leveling, grading, and cleanup jobs that make it one of the most useful first tools to own. It is the kind of implement that quickly proves its value the moment real work starts ...

Corebridge Financial and Equitable Holdings have agreed to an all-stock merger valued at approximately $22 billion that will create a life insurance, annuity, wealth and asset management company ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. In early March the U.S. Food and Drug Administration sent a warning letter to Novo ...

Brianna "Chickenfry" LaPaglia is slamming the use of Ozempic for weight loss. The reality TV star and Barstool Sports personality, 26, got candid about the growing use of GLP-1 weight loss medications ...